HEDIS MY 2022 Digital Measures Bundle
HEDIS Digital Quality Measures (dQMs) are digitalized versions of existing HEDIS measures—the kind of measures that plans have used and reported to NCQA since the early 1990’s. Advantages of digital measures include easier transfer of measures into your IT system, less interpretation, recoding and human error and harmonization with industry standards.
HEDIS dQMs offer:
- Ease: Reduce burden—and risk—of manually reading, interpreting and recoding measure specs.
- Accuracy: Use machine-to-machine instructions, programmed by NCQA, to set and simplify measure calculations.
- Usability: Report measures for HEDIS MY 2022 and other quality reporting programs—possible because measures use Health Level Seven International (HL7®) standard Clinical Quality Language (CQL).
The HEDIS MY 2022 Digital Measures Bundle is a totally configurable product, offering a choice of any of the following 22 digital quality measures (dQMs) in FHIR® (Fast Healthcare Interoperability Resources) format:
| For Electronic Clinical Data System (ECDS) Reporting | For Traditional Reporting | |
| Adult Immunization Status (AIS-E) | ✔ | |
| Appropriate Testing for Pharyngitis (CWP) | ✔ | |
| Appropriate Treatment for Upper Respiratory Infection (URI) | ✔ | |
| Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) | ✔ | |
| Breast Cancer Screening (BCS-E) | ✔ | |
| Cervical Cancer Screening (CCS) | ✔ | |
| Childhood Immunization Status (CIS-E) | ✔ | ✔ |
| Colorectal Cancer Screening (COL-E) | ✔ | |
| Depression Remission or Response for Adolescents and Adults (DRR-E) | ✔ | |
| Depression Screening and Follow-Up for Adolescents and Adults (DSF-E) | ✔ | |
| Follow-Up After Emergency Department Visit for Mental Illness (FUM) | ✔ | |
| Follow-Up Care for Children Prescribed ADHD Medication (ADD-E) | ✔ | |
| Immunizations for Adolescents (IMA-E) | ✔ | ✔ |
| Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) | ✔ | ✔ |
| Non-Recommended PSA-Based Screening in Older Men (PSA) | ✔ | |
| Postpartum Depression Screening and Follow-Up (PDS-E) | ✔ | |
| Prenatal Depression Screening and Follow-Up (PND-E) | ✔ | |
| Prenatal Immunization Status (PRS-E) | ✔ | |
| Risk of Continued Opioid Use (COU) | ✔ | |
| Unhealthy Alcohol Use Screening and Follow-Up (ASF-E) | ✔ | |
| Use of Opioids from Multiple Providers (UOP) | ✔ | |
| Utilization of the PHQ-9 to Monitor Depression Symptoms for Adolescents and Adults (DMS-E) | ✔ |
